News

Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL: Cambridge, UK Wednesday, July 23, 2025, 16: ...
A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute myeloid leukemia, one of the most aggressive and fatal blood cancers in adults.
A recent study reveals a concerning link between childhood leukemia and proximity to oil and natural gas wells. Colorado ...
French biotech ImCheck Therapeutics has announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its lead program, ICT01, a humanized anti-butyrophilin 3A (BTN3A ...
Olli Spiller, 15, is currently being treated for acute myeloid leukaemia at the Royal Victoria Infirmary's Teenage Cancer ...
Mild CMV reactivation was associated with beneficial effects, while severe cases required treatment, which increased the risk of toxicity and infections.
Cycle Pharmaceuticals (Cycle Pharma) has entered into an exclusive U.S. commercialization agreement with Handa Therapeutics, ...
Of 34 CMML treatment-naïve participants enrolled and treated with lenzilumab plus azacitidine, 22 have evaluable responses in the first twelve months of follow-up - Building upon previously reported ...
Gaining insights into the complex pathways and key cell populations involved in immune dysregulation can aid the development ...
His mother Tara, father Blake and sister Kalirae live near Badger Canyon. They are hosting a celebration of life at the ...
A frequent visitor to Dodger Stadium in his capacity with MLB, the trailblazer who died last year at age 60 was honored for ...